169 related articles for article (PubMed ID: 29732516)
21. Association of surgical resection and survival in patients with malignant primary osseous spinal neoplasms from the Surveillance, Epidemiology, and End Results (SEER) database.
Mukherjee D; Chaichana KL; Parker SL; Gokaslan ZL; McGirt MJ
Eur Spine J; 2013 Jun; 22(6):1375-82. PubMed ID: 23263168
[TBL] [Abstract][Full Text] [Related]
22. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
[TBL] [Abstract][Full Text] [Related]
23. Fast neutron therapy for inoperable or recurrent sacrococcygeal chordomas.
Breteau N; Demasure M; Favre A; Leloup R; Lescrainier J; Sabattier R
Bull Cancer Radiother; 1996; 83 Suppl():142s-5s. PubMed ID: 8949767
[TBL] [Abstract][Full Text] [Related]
24. Carbon ion beam treatment in patients with primary and recurrent sacrococcygeal chordoma.
Uhl M; Welzel T; Jensen A; Ellerbrock M; Haberer T; Jäkel O; Herfarth K; Debus J
Strahlenther Onkol; 2015 Jul; 191(7):597-603. PubMed ID: 25737378
[TBL] [Abstract][Full Text] [Related]
25. Outcomes following attempted en bloc resection of cervical chordomas in the C-1 and C-2 region versus the subaxial region: a multiinstitutional experience.
Molina CA; Ames CP; Chou D; Rhines LD; Hsieh PC; Zadnik PL; Wolinsky JP; Gokaslan ZL; Sciubba DM
J Neurosurg Spine; 2014 Sep; 21(3):348-56. PubMed ID: 24926926
[TBL] [Abstract][Full Text] [Related]
26. Sacral chordoma: 40-year experience at a major cancer center.
York JE; Kaczaraj A; Abi-Said D; Fuller GN; Skibber JM; Janjan NA; Gokaslan ZL
Neurosurgery; 1999 Jan; 44(1):74-9; discussion 79-80. PubMed ID: 9894966
[TBL] [Abstract][Full Text] [Related]
27. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
[TBL] [Abstract][Full Text] [Related]
28. Socioeconomic Predictors of Surgical Resection and Survival for Patients With Osseous Spinal Neoplasms.
Deb S; Brewster R; Pendharkar AV; Veeravagu A; Ratliff J; Desai A
Clin Spine Surg; 2019 Apr; 32(3):125-131. PubMed ID: 30531357
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.
Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM
Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725
[TBL] [Abstract][Full Text] [Related]
30. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.
Varga PP; Szövérfi Z; Fisher CG; Boriani S; Gokaslan ZL; Dekutoski MB; Chou D; Quraishi NA; Reynolds JJ; Luzzati A; Williams R; Fehlings MG; Germscheid NM; Lazary A; Rhines LD
Eur Spine J; 2015 May; 24(5):1092-101. PubMed ID: 25533857
[TBL] [Abstract][Full Text] [Related]
31. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
[TBL] [Abstract][Full Text] [Related]
32. Sacrectomy and adjuvant radiotherapy for the treatment of sacral chordomas: a single-center experience over 27 years.
Dhawale AA; Gjolaj JP; Holmes L; Sands LR; Temple HT; Eismont FJ
Spine (Phila Pa 1976); 2014 Mar; 39(5):E353-9. PubMed ID: 24365895
[TBL] [Abstract][Full Text] [Related]
33. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
[TBL] [Abstract][Full Text] [Related]
34. Chordomas: Histopathological Study in View of Anatomical Location.
Cha YJ; Suh YL
J Korean Med Sci; 2019 Apr; 34(13):e107. PubMed ID: 30950252
[TBL] [Abstract][Full Text] [Related]
35. Low expression of PHLPP1 in sacral chordoma and its association with poor prognosis.
Chen H; Zhang K; Wu G; Song D; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(11):14741-8. PubMed ID: 26823799
[TBL] [Abstract][Full Text] [Related]
36. Sacrococcygeal chordomas in children.
Richards AT; Stricke L; Spitz L
J Pediatr Surg; 1973 Dec; 8(6):911-4. PubMed ID: 4785565
[No Abstract] [Full Text] [Related]
37. [Treatment results in chordomas of the saccrococcygeal area].
Knysh IT; Tolstopiatov BA
Vopr Onkol; 1982; 28(6):55-9. PubMed ID: 7090298
[TBL] [Abstract][Full Text] [Related]
38. Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry.
Lee J; Bhatia NN; Hoang BH; Ziogas A; Zell JA
J Bone Joint Surg Am; 2012 Feb; 94(4):356-63. PubMed ID: 22336975
[TBL] [Abstract][Full Text] [Related]
39. The treatment outcome depending on the extent of resection in skull base and spinal chordomas.
Eid AS; Chang UK; Lee SY; Jeon DG
Acta Neurochir (Wien); 2011 Mar; 153(3):509-16. PubMed ID: 21207074
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Raf-1 and ERK1/2 in sacral chordoma and association with tumor recurrence.
Zhang K; Chen H; Zhang B; Sun J; Lu J; Chen K; Yang H
Int J Clin Exp Pathol; 2015; 8(1):608-14. PubMed ID: 25755752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
